Case report demonstrates successful embryo selection via direct detection and haplotyping in a de novo TP63 carrier, suggesting feasibility of family-independent preimplantation testing.
Objective Ectrodactyly–ectodermal dysplasia–clefting (EEC) syndrome is a rare autosomal dominant disorder caused by TP63 variants. De novo mutations challenge preimplantation genetic testing for monogenic disorders (PGT-M) when informative relatives are unavailable. This report describes a proband-independent PGT-M workflow for a de novo TP63 variant. Case report Whole-exome sequencing identified a heterozygous TP63 c.925A > G variant in a 34-year-old male with EEC features, with germline transmission confirmed in sperm DNA. A customized PGT-M workflow combined direct mutation detection with short tandem repeat–based haplotype analysis using informative markers closely linked to TP63. Embryos from three IVF cycles underwent combined PGT-M and preimplantation genetic testing for aneuploidy (PGT-A). Among 17 blastocysts, 6 were low-risk for the TP63 variant, and 2 were euploid. Transfer of one euploid, low-risk embryo resulted in a healthy infant without the pathogenic variant. Conclusion This case supports the feasibility of a proband-independent PGT-M strategy for de novo TP63-related EEC syndrome.
No takes yet. Share an insight, caveat, or question.
Chien et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: